Strategic acquisitions Alcidion is expanding through strategic asset purchases, notably the Kyra flow products from Telstra Health, signaling a growth trajectory and potential cross-sell opportunities for Miya Precision alongside Kyra capabilities.

Patient flow expansion Recent client wins and deployments focus on bed management, patient flow, and remote patient monitoring, indicating a market need for comprehensive care coordination and real-time operational visibility that Miya Precision can further enhance.

Public sector traction Multiple NHS and regional health system deployments demonstrate government-adjacent sales potential and the importance of scalable, compliant digital ecosystems for public healthcare customers.

AI compliant growth Launch of Concept Detection to meet SaMD certification requirements positions Alcidion to offer clinician-supportive AI with regulatory alignment, opening doors to health systems prioritizing compliant AI tools.

Platform modularity MiYa Precision’s modular, interoperable approach aligns with diverse regional needs and patient demographics, suggesting opportunities to upsell modules such as patient flow, RPM, and advanced data exchange across new sites.